{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:05:41Z","timestamp":1790867141786,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vaccine.2007.12.059","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T10:04:29Z","timestamp":1202897069000},"page":"1794-1804","source":"Crossref","is-referenced-by-count":41,"title":["Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine"],"prefix":"10.1016","volume":"26","author":[{"given":"Audrey","family":"Ferrier-Rembert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Drillien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Crance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.12.059_bib1","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"22","key":"10.1016\/j.vaccine.2007.12.059_bib2","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.12.059_bib3","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2007.12.059_bib4","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.059_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.059_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.12.059_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.12.059_bib8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2004.08.050","article-title":"Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice","volume":"23","author":"Hanke","year":"2005","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.12.059_bib9","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol [B]"},{"issue":"27","key":"10.1016\/j.vaccine.2007.12.059_bib10","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.12.059_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"12","key":"10.1016\/j.vaccine.2007.12.059_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2007.12.059_bib13","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.12.059_bib14","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.12.059_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0042-6822(81)90351-2","article-title":"Host range deletion mutant of vaccinia virus defective in human cells","volume":"111","author":"Drillien","year":"1981","journal-title":"Virology"},{"issue":"6979","key":"10.1016\/j.vaccine.2007.12.059_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.12.059_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vaccine.2006.07.022","article-title":"Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine","volume":"25","author":"Phelps","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.059_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.12.059_bib19","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1016\/j.vaccine.2007.04.011","article-title":"Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines","volume":"25","author":"Ferrier-Rembert","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.059_bib20","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1016\/j.vaccine.2007.09.050","article-title":"Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate","volume":"25","author":"Ferrier-Rembert","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.12.059_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0042-6822(62)90172-1","article-title":"The purification of four strains of poxvirus","volume":"18","author":"Joklik","year":"1962","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.059_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2004.07.005","article-title":"Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation","volume":"32","author":"Leparc-Goffart","year":"2005","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.12.059_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1189\/jlb.1002506","article-title":"Fever-like thermal conditions regulate the activation of maturing dendritic cells","volume":"73","author":"Tournier","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.12.059_bib24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.12.059_bib25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals","volume":"25","author":"Parrino","year":"2007","journal-title":"Vaccine"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2007.12.059_bib26","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/vir.0.80646-0","article-title":"Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara","volume":"86","author":"Staib","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.12.059_bib27","series-title":"Vaccines","author":"Henderson","year":"1999"},{"issue":"1","key":"10.1016\/j.vaccine.2007.12.059_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/vim.2006.0091","article-title":"CD4+ T cells play a pivotal role in the control of cowpox virus infection in mice","volume":"20","author":"Ferrier-Rembert","year":"2007","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2007.12.059_bib29","unstructured":"EMEA cfpmp. Note for guidance on the development of vaccinia virus based vaccines against smallpox. EMEA report 2002:1\u201319."},{"issue":"11","key":"10.1016\/j.vaccine.2007.12.059_bib30","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-{gamma}-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T14:55:22Z","timestamp":1546268122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07014880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":30,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0264410X07014880"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}